SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 270 filers reported holding SAGE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,601 | -56.2% | 175 | 0.0% | 0.00% | – |
| Q2 2023 | $8,228 | +12.1% | 175 | 0.0% | 0.00% | – |
| Q1 2023 | $7,343 | +104800.0% | 175 | -5.4% | 0.00% | – |
| Q4 2022 | $7 | -99.9% | 185 | 0.0% | 0.00% | – |
| Q3 2022 | $7,000 | +40.0% | 185 | +5.7% | 0.00% | – |
| Q2 2022 | $5,000 | -16.7% | 175 | -9.8% | 0.00% | – |
| Q1 2022 | $6,000 | -14.3% | 194 | +10.9% | 0.00% | – |
| Q4 2021 | $7,000 | 0.0% | 175 | 0.0% | 0.00% | – |
| Q3 2021 | $7,000 | -30.0% | 175 | 0.0% | 0.00% | – |
| Q2 2021 | $10,000 | -23.1% | 175 | 0.0% | 0.00% | – |
| Q1 2021 | $13,000 | -13.3% | 175 | 0.0% | 0.00% | – |
| Q4 2020 | $15,000 | +36.4% | 175 | 0.0% | 0.00% | – |
| Q3 2020 | $11,000 | +57.1% | 175 | 0.0% | 0.00% | – |
| Q2 2020 | $7,000 | +40.0% | 175 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | -66.7% | 175 | -14.6% | 0.00% | -100.0% |
| Q4 2019 | $15,000 | – | 205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 181,650 | $15,715,000 | 7.17% |
| GREAT POINT PARTNERS LLC | 454,417 | $39,312,000 | 6.38% |
| ACUTA CAPITAL PARTNERS, LLC | 255,800 | $22,129,000 | 6.02% |
| Integral Health Asset Management, LLC | 195,000 | $16,869,000 | 5.02% |
| DAFNA Capital Management LLC | 181,306 | $15,685,000 | 4.67% |
| Boxer Capital, LLC | 1,094,000 | $94,642,000 | 3.04% |
| Palo Alto Investors LP | 590,200 | $51,058,000 | 2.68% |
| Bellevue Group AG | 1,567,504 | $135,604,000 | 1.55% |
| Aristotle Atlantic Partners, LLC | 160,805 | $13,911,000 | 1.07% |
| JGP Global Gestao de Recursos Ltda. | 2,618 | $226,000 | 0.85% |